GB2106908A - Alkoxyvincamone derivatives - Google Patents
Alkoxyvincamone derivatives Download PDFInfo
- Publication number
- GB2106908A GB2106908A GB08227827A GB8227827A GB2106908A GB 2106908 A GB2106908 A GB 2106908A GB 08227827 A GB08227827 A GB 08227827A GB 8227827 A GB8227827 A GB 8227827A GB 2106908 A GB2106908 A GB 2106908A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- compounds
- cuprous
- catalyst
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A process for the preparation of alkoxyvincamone derivatives of the formula (I> <IMAGE> (wherein R<1> and R<2>, which may be the same or different, each represents an alkyl group having from 1 to 6 carbon atoms) comprising reacting a halovincaminic acid ester of the formula (II> <IMAGE> (wherein R<2> is as defined above R<3> represents an alkyl group having from 1 to 6 carbon atoms, and X represents a halogen atom) with an alkali metal alkanoate of the formula R<1>-OMe, (wherein R<1> is as defined above and Me represents an alkali metal atom), in the presence of a catalyst. Compounds of formula I other than (-)-vincinone are also claimed.
Description
SPECIFICATION
Alkoxyvincamone derivatives
The invention relates to a new process for the preparation of alkoxyvincamone derivatives of the formula (I)
(wherein R' and R2, which may be the same or different, each represents an alkyl group having from 1 to 6 carbon atoms).
The compounds of formula (I) are pharmaceutically active as well as being useful starting materials in the preparation of other pharmaceutically active compounds having an eburnane skeleton. These compounds are new compounds except for (- )-vincinone, i.e. a compound of the formula (I), in which R2 is an a-ethyl group, R' is methyl, the R10 group is attached to the 11-position of the eburnane skeleton and the hydrogen is in position which is known.Thus (- )-vincinone occurs naturally in Vinca minor [Tetrahedron Letters 15, 1805-1806 (1968)] and can be prepared synthetically by nitrating (- )-vincamone (yield: 77%), reducing the 11nitro-vincamone obtained (yield: 80%), diazoting the 11-amino-vincamone obtained, converting the formed diazonium salt into 1 1-hydroxy-vincamone directly, without isolation, in a known manner (yield: 50%) and finally reacting the 1 1-hydroxy-vincamone produced with diazomethane to produce (- )-vincinone (yield: 30%). However the total yield of the five subsequent reaction steps is only 9.2% [see Bull. Soc. Chim. Belg. 88. 93 (1979)1.
We have now surprisingly found that by reacting halovincaminic acid esters with alkali metal alkanoates of the formula R1-OMe containing the desired R'O moiety in the presence of a suitable catalyst, not only (- )-vincinone but also the other alkoxyvincamone derivatives of formula (I), may be obtained in a single reaction step, with a 66% yield.
Thus according to the present invention we provide a process for the preparation of alkoxyvincamone derivatives of the formula (I) as hereinbefore defined which comprises reacting a halovincaminic acid ester of the formula (II)
(wherein R2 is as defined above, R3 represents an alkyl group having from 1 to 6 carbon atoms and X represents a halogen atom) with an alkali metal alkanoate of the formula R1-OMe, (wherein R' is as defined above and Me represents an alkali metal atom), in the presence of a catalyst.
In the definition of R1, R2 and R3 the term "alkyl having from 1 to 6 carbon atoms" is used to refer to straight or branched chained alkyl groups having from one to 6 carbon atoms, e.g.
methyl, ethyl, rrpropyl, iso-propyl, butyl, sec-butyl, tert-butyl, rrpentyl, iso-pentyl, hexyl or isohexyl, preferably methyl or ethyl. X may represent fluorine, chlorine, bromine or iodine, preferably bromine.
In the formula (I) the group R10 may be attached to the benzene ring in any position and the actual site of attachment depends on the position of X in the starting materials of the formula (II). The 9-, 10- and 1 1-alkoxy-vincamones are preferred.
The starting compounds of the formula (II) can for example be prepared as described in
Hungarian Patent Application Rl-675 and Hungarian Patent Specification 1 78 702.
As a catalyst in the reaction of the compounds of formula (11) with alkali metal alkanoates of the formula R1-OMe for example an inorganic salt containing a monovalent copper ion can be employed. Such catalysts include, for example, cuprous iodide, cuprous rhodanide, cuprous chloride and cuprous bromide, cuprous bromide being preferred.
As a solvent for example alkanols of the formula R'-OH, corresponding to the R'-OMe reactant and dimethylformamide, dimethylacetamide, 2,4,6-collidine, 2,6-lutidine or pyridine, preferably dimethylformamide are employed. The reaction is preferably carried out at a temperature of from 25"C to 140"C.
Relative to the starting compounds of the formula (II) preferably 3 to 1 5 equivalents of the alkanoate of formula R1-OMe and 0.5 to 4 equivalents of cuprous salt are used.
Further details of the invention are illustrated by the following example which is for illustration and not for limitation of our invention.
Example (- )-Vincanone [(- )-1 1-methoxy-vincamone] 0.12 g. (5.21 mmoles) of sodium metal are dissolved in 1.6 ml. of absolute methanol, under nitrogen. To the solution 2.5 ml. of absolute dimethylformamide and 0.25 g. (1.31 mmoles) of cuprous iodide are added followed by the addition of 0.20 g. (0.46 mmoles) of (+ )-1 1-bromo- vincamine (Hungarian Patent Specification 1 78 702). The reaction mixture is allowed to stand at 110"C for 1.5 hours, with continuous stirring. Upon cooling the mixture is poured onto 7 ml.
of ice water, shaken with 5 ml. of ethyl acetate and the inorganic precipitate is filtered off. The organic phase is separated from the filtrate and the aqueous phase is extracted with three 5-ml.
portions of ethyl acetate. The combined ethyl acetate phases are shaken with two 3-ml. portions of water, the organic layer is dried with solid, anhydrous magnesium sulfate, filtered and from the filtrate the solvent is eliminated in vacuo. The residual oil is crystallized from 1 ml. of methanol. 0.10 g. (66%) of the title compound are obtained.
Melting point: 1 68 to 1 70 C (methanol)
(Literature melting point data: 1 61 to 1 62'C (acetone) -Bull. Soc. Chim. Belg. 88, 93 (1979);
168 to 169"C -Tetrahedron Letters, 1968, 1805;
169 to 170"C Collect. Czech. Chem. Commun. 29, 447, 1964).
IR (KBr): 1700 (lactame CO); 1620 cm-' (aromatic)
Mass spectrum m/e (%): 324 (M+, C20H24N202, 100); 323 (80); 296 (12); 295 (26); 294
(8.8); 293 (8.3); 267 (18); 254 (20); 252 (8.3); 197 (9.4).
Cu]o = 1 12 2; [a]54= = - 137.70 (c = 0.70; chloroform).
(Literature data: [a]D = - 107" (c = 0.37; chloroform9Bull. Soc. Chim. Belg. 88, 93, 1979); - 118' (Tetrahedron Letters, 1968, 1805].
Claims (12)
1. A process for the preparation of alkoxyvincamone derivatives of the formula (I)
(wherein R' and R2, which may be the same or different, each represents an alkyl group having from 1 to 6 carbon atoms) which comprises reacting a halovincaminic acid ester of the formula (II)
(wherein R2 is as defined above, R3 represents an alkyl group having from 1 to 6 carbon atoms and X represents a halogen atom) with an alkali metal alkanoate of the formula R'-OMe, (wherein R' is as defined above and Me represents an alkali metal atom), in the presence of a catalyst.
2. A process as claimed in claim 1 wherein the catalyst is a cuprous salt.
3. A process as claimed in claim 2 wherein the catalyst is cuprous iodide, cuprous rhodanide, cuprous chloride or cuprous bromide.
4. A process claimed in any preceding claim wherein the reaction is effected in the presence of a solvent.
5. A process as claimed in claim 4 wherein the solvent comprises an alkanol of formula R'OH (wherein R' is as defined in claim 1) and dimethylformamide, dimethylacetamide, 2,4,6collidine, 2,4-lutidine or pyridine.
6. A process as claimed in any preceding claim wherein X in the compound of formula (II) is in the 9-, 10- or 11-position.
7. A process as claimed in any preceding claim wherein X represents a bromine atom.
8. A process for preparation of compounds of general formula I as claimed in claim 1 substantially as herein described.
9. A process for preparation of compounds of general formula I as defined in claim 1 substantially as herein described in the Example.
10. Compounds of general formula I as defined in claim 1 whenever prepared by a process as claimed in any one of claims 1 to 9.
11. Compounds of general formula I as defined in claim 1 other than (--)-vincinone.
12. Each and every novel method, process, compound and composition herein disclosed.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU281181A HU183594B (en) | 1981-09-30 | 1981-09-30 | Process for producing 11-methoxy-vincamone |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2106908A true GB2106908A (en) | 1983-04-20 |
GB2106908B GB2106908B (en) | 1985-05-30 |
Family
ID=10961201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08227827A Expired GB2106908B (en) | 1981-09-30 | 1982-09-29 | Alkoxyvincamone derivatives |
Country Status (4)
Country | Link |
---|---|
AT (1) | AT380249B (en) |
BE (1) | BE894555A (en) |
GB (1) | GB2106908B (en) |
HU (1) | HU183594B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5093337A (en) * | 1987-11-19 | 1992-03-03 | Roussel Uclaf | Substituted derivatives of 20,21-dinoreburnamenine, their use as medicaments and the pharmaceutical compositions containing them |
-
1981
- 1981-09-30 HU HU281181A patent/HU183594B/en not_active IP Right Cessation
-
1982
- 1982-09-29 AT AT360082A patent/AT380249B/en not_active IP Right Cessation
- 1982-09-29 GB GB08227827A patent/GB2106908B/en not_active Expired
- 1982-09-30 BE BE0/209138A patent/BE894555A/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5093337A (en) * | 1987-11-19 | 1992-03-03 | Roussel Uclaf | Substituted derivatives of 20,21-dinoreburnamenine, their use as medicaments and the pharmaceutical compositions containing them |
Also Published As
Publication number | Publication date |
---|---|
GB2106908B (en) | 1985-05-30 |
BE894555A (en) | 1983-03-30 |
AT380249B (en) | 1986-04-25 |
HU183594B (en) | 1984-05-28 |
ATA360082A (en) | 1985-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4557866A (en) | Process for the synthesis of pyrido-imidazo rifamycins | |
KR970003125B1 (en) | METHOD FOR PRODUCING Ñß,ÑÔ-UNSATURATED KETOLACTONES | |
USRE32518E (en) | Camptothecin derivatives | |
US3897417A (en) | Process for the preparation of steroidal spirolactones and intermediates | |
GB2106908A (en) | Alkoxyvincamone derivatives | |
IL38023A (en) | Isoindoline derivatives and process for their preparation | |
US4687859A (en) | Monoesters of imidazolidinone dicarboxylic acids | |
JPS61225183A (en) | Manufacture of beta-carboline | |
US5708164A (en) | Cephalostatin analogues | |
US4429129A (en) | 1α-Ethyl-1β-(2'-alkoxy carbonyl-2'-hydroxyiminoethyl)-10-methoxy 1,2,3,4,6,7,12,12β-octahydroindolo(2,3A)quinolizines | |
US4355166A (en) | Quinuclidinic ester and derivatives of phenoxycarboxylic acids | |
HU202518B (en) | Process for producing 5-chloro-3-chloro-sulfonyl-2-thiophenecarboxylic acid esters | |
US4329350A (en) | 1,1-Disubstituted octahydro-indolo[2,3-a]quinolizines, process for the preparation thereof and compositions containing same | |
JPH0314030B2 (en) | ||
JP3171400B2 (en) | Hydroxycarbonyl derivative and method for producing the same | |
KR100248370B1 (en) | Preparation of intermediate of (-)-3(s)-methylpyrido benzoxizine derivative | |
CS219347B2 (en) | Method of preparation of the 1-hydroxyaporfin derivative | |
HU187336B (en) | New process for producing intermediates of carbacycline | |
EP0050492A1 (en) | 1,1-Disubstituted-hexahydro-indolo(2,3-a)quinolizine derivatives and their use in the enantioselective synthesis of optically active 14-oxo-E-homo-eburnane derivatives | |
US4051150A (en) | 3-(2-Dialkylamino-2-dialkylphosphonylvinyl)-6,11-dihydrodibenzo-[b.e.]-thiepin-11-one | |
EP0494771B1 (en) | Process for producing optically active dihydropyran derivatives | |
PL116341B1 (en) | Process for preparing novel 5,8-dihydrofuro/3,2-b/-1,8-naphtiridine compounds | |
JPS6129351B2 (en) | ||
CH658059A5 (en) | METHOD FOR PRODUCING 10-BROMINE VINCAMINES. | |
KR0179320B1 (en) | (+-)-2-(tolylsulfinyl)-cyclopentadecan-1-one and process for preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |